Cargando…

Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes

Whether sitagliptin may increase thyroid cancer risk has not been investigated in the Asian populations. This study evaluated the association in Taiwanese patients with newly diagnosed type 2 diabetes from 1999 to 2008 by using the reimbursement database of the National Health Insurance. They should...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tseng, Chin-Hsiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029749/ https://www.ncbi.nlm.nih.gov/pubmed/27029076 http://dx.doi.org/10.18632/oncotarget.8399

Ejemplares similares

Sitagliptin and oral cancer risk in type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2017)

Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016)

Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016)

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014)

Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014)

Metformin use and cervical cancer risk in female patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017)

Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Metformin may reduce oral cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2015)

Thyroid Cancer Risk Is Not Increased in Diabetic Patients
por: Tseng, Chin-Hsiao
Publicado: (2012)

Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)

Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2019)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
por: Zeng, De-kang, et al.
Publicado: (2019)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

The durability of sitagliptin in elderly patients with type 2 diabetes
por: Hsieh, Ching-Jung, et al.
Publicado: (2014)

Sex-Related Differences in Sitagliptin Treatment in Type 2 Diabetes: Results from the PROLOGUE Trial
por: Wu, Xilin, et al.
Publicado: (2022)

Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients
por: Sun, Yue, et al.
Publicado: (2020)

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin
por: Jameshorani, Maryam, et al.
Publicado: (2017)

Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin
por: Wilson, Jessica R., et al.
Publicado: (2017)

Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2015)

Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin‐Hsiao
Publicado: (2018)

Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2019)

The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017)

Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis
por: Tseng, Chin-Hsiao
Publicado: (2022)

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
por: Ohki, Takamasa, et al.
Publicado: (2012)

Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
por: Tseng, Chin-Hsiao
Publicado: (2023)

Protective Effect of Sitagliptin and Rosuvastatin Combination on Vascular Endothelial Dysfunction in Type-2 Diabetes
por: Nade, Vandana S., et al.
Publicado: (2015)

Diabetes and Thyroid Cancer Risk: Literature Review
por: Shih, Shyang-Rong, et al.
Publicado: (2012)

Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
por: Tseng, Chin-Hsiao
Publicado: (2018)

Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone
por: Tseng, Chin-Hsiao
Publicado: (2019)

The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin
por: Tseng, Chin-Hsiao
Publicado: (2023)

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2020)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015)

Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1m5t7ica3325rj9r306ajfp672